[Responsibility for patient education in drug therapy from the viewpoint of the drug industry].
Lerch
C
C
Robert-Koch-Institut, Berlin.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D005858:Germany; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence*
Aufklärungspflicht bei medikamentöser Therapie aus Sicht der Zulassungsbehörde.